Inhibition of adenosine deaminase by co-vidarabine and its effect on the metabolic disposition of adenine arabinoside (vidarabine). 1977

P E Borondy, and T Chang, and E Maschewske, and A J Glazko

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D009700 Nucleoside Deaminases Catalyze the hydrolysis of nucleosides with the elimination of ammonia. Deaminases, Nucleoside
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

P E Borondy, and T Chang, and E Maschewske, and A J Glazko
January 1979, Journal of medical virology,
P E Borondy, and T Chang, and E Maschewske, and A J Glazko
May 1976, Research communications in chemical pathology and pharmacology,
P E Borondy, and T Chang, and E Maschewske, and A J Glazko
November 1974, Antimicrobial agents and chemotherapy,
P E Borondy, and T Chang, and E Maschewske, and A J Glazko
July 1972, Biochemistry,
P E Borondy, and T Chang, and E Maschewske, and A J Glazko
January 1980, The Journal of surgical research,
P E Borondy, and T Chang, and E Maschewske, and A J Glazko
March 1977, Annals of the New York Academy of Sciences,
P E Borondy, and T Chang, and E Maschewske, and A J Glazko
March 1982, Biochemical pharmacology,
P E Borondy, and T Chang, and E Maschewske, and A J Glazko
January 1985, Annals of the New York Academy of Sciences,
P E Borondy, and T Chang, and E Maschewske, and A J Glazko
November 1985, Journal of medicinal chemistry,
Copied contents to your clipboard!